AVTX Competitors & Alternatives
Compare Avalo Therapeutics Inc with similar stocks in the same industry
Biotechnology
AVTX
Main Stock$19.95
Tradestie Score
56
Market Cap
$170.45M
Revenue Growth
-0.7%
Analyst Upside
+124.0%
Top Competitors
239 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
PHAR
Pharming Group N.V. ADS, each representing 10 ordinary shares
|
$14.04
|
$1.05B | 76.1 | 54 | Compare |
|
MDXG
MiMedx Group, Inc
|
$4.14
|
$1.01B | 21.3 | 67 | Compare |
|
SPRY
ARS Pharmaceuticals, Inc. Common Stock
|
$7.88
|
$997.16M | - | 55 | Compare |
|
PRME
Prime Medicine, Inc. Common Stock
|
$4.23
|
$996.55M | - | 58 | Compare |
|
SYRE
Spyre Therapeutics, Inc. Common Stock
|
$98.75
|
$994.20M | - | 59 | Compare |
|
VALN
Valneva SE American Depositary Shares
|
$5.30
|
$993.46M | - | 57 | Compare |
|
IMNM
Immunome, Inc.
|
$24.17
|
$987.09M | - | 56 | Compare |
|
BBOT
BridgeBio Oncology Therapeutics, Inc. Common Stock
|
$9.09
|
$952.74M | - | 64 | Compare |
|
SANA
Sana Biotechnology, Inc. Common Stock
|
$3.93
|
$951.83M | - | 61 | Compare |
|
MNMD
Mind Medicine (MindMed) Inc. Common Shares
|
$15.02
|
$938.16M | - | 62 | Compare |
More AVTX Analysis
Data updated: Jul 09, 2026 | Industry: Biotechnology (SIC 2834)
239 stocks in this industry